Orexigen Therapeutics, Inc. recalls Contrave (naltrexone HCl and bupropion HCl). Extended-Release Tablets, 8mg/90 mg, 120-count bottles, Rx only, Distribute
Recalled November 14, 2018 · FDA recall D-0219-2019 · Orexigen Therapeutics
Hazard
Container packaging defect. · FDA Class III
Units
18,895 bottles
Sold at
Within the United States
Description
Container packaging defect.
Product
Contrave (naltrexone HCl and bupropion HCl). Extended-Release Tablets, 8mg/90 mg, 120-count bottles, Rx only, Distributed by Orexigen therapeutics, Inc., La Jolla, CA 92037, NDC 51267-890-99
Manufacturer(s)
Orexigen Therapeutics, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →